Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis

Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Dis Markers
Glavni autori: Lu, Hsing-Fang, Chou, Po-Hsin, Lin, Gan-Hong, Chou, Wan-Hsuan, Wang, Shih-Tien, Adikusuma, Wirawan, Mugiyanto, Eko, Hung, Kuo-Sheng, Chang, Wei-Chiao
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479487/
https://ncbi.nlm.nih.gov/pubmed/32934756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8855423
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items